Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Women With Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00082667
What this trial is testing

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00074100
What this trial is testing

Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01723592
What this trial is testing

Orall Administered Probiotics to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy.

Who this might be right for
Breast Cancer
Medical University of Vienna 27
Not applicableUnknownNCT02992730
What this trial is testing

Predictors of Adjuvant Endocrine Therapy in Women With Breast Cancer

Who this might be right for
Breast Cancer Female
Georgetown University 630
Not applicableStudy completedNCT00418444
What this trial is testing

Body Image and Psychosocial Functioning in Women With Breast Cancer: Can We Fix What We've Broken?

Who this might be right for
Breast Neoplasms
University Health Network, Toronto 180
Post-approval studies (Phase 4)Ended earlyNCT05183828
What this trial is testing

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Washington 62
Not applicableLooking for participantsNCT05649072
What this trial is testing

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Who this might be right for
Ovarian CancerBreast CancerColorectal Cancer
M.D. Anderson Cancer Center 1,000
Not applicableEnded earlyNCT01303419
What this trial is testing

Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
GE Healthcare 224
Testing effectiveness (Phase 2)Looking for participantsNCT04503265
What this trial is testing

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant NeoplasmBreast CancerOvarian Cancer+3 more
AtlasMedx, Incorporated 122
Early research (Phase 1)UnknownNCT05273944
What this trial is testing

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients

Who this might be right for
Breast CancerOvarian Cancer
Shenzhen Kangzhe Pharmaceutical Co., Ltd. 80
Large-scale testing (Phase 3)UnknownNCT00966888
What this trial is testing

Radiation Therapy or Standard Therapy in Treating Women With Stage II Breast Cancer Who Have Undergone Mastectomy

Who this might be right for
Breast Cancer
Medical Research Council 3,500
Post-approval studies (Phase 4)Study completedNCT05631795
What this trial is testing

Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment

Who this might be right for
Advanced Breast Cancer
Novartis Pharmaceuticals 40
Not applicableNot Yet RecruitingNCT07331077
What this trial is testing

A Physical Activity Program Compared to Health Education for Improving Memory and Attention in Hispanic Women With Newly-Diagnosed Stage I-IIIa Breast Cancer, MAMA Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+1 more
Mayo Clinic 10
Testing effectiveness (Phase 2)Study completedNCT00316407
What this trial is testing

Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients

Who this might be right for
Ovarian Epithelial Cancer Stage IIIStage IV Ovarian CancerStage IV Breast Cancer
Swedish Medical Center 30
Early research (Phase 1)Study completedNCT00001302
What this trial is testing

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Who this might be right for
Breast CancerKidney NeoplasmLymphoma+2 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Not applicableUnknownNCT06080607
What this trial is testing

PRO Survivorship Concerns ITA

Who this might be right for
Breast Neoplasm FemaleQuality of LifePsychological Distress
Regina Elena Cancer Institute 280
Testing effectiveness (Phase 2)WithdrawnNCT01137994
What this trial is testing

A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline
Not applicableStudy completedNCT00342953
What this trial is testing

Study of Health Effects of Cosmetic Breast Augmentation

Who this might be right for
Brain CancerBreast CancerLung Cancer+1 more
National Cancer Institute (NCI) 17,424
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Next Page